[Therapeutic Angiogenesis Using Growth Factors: Current State and Prospects for Development]

Area of Science:

• Regenerative Medicine
• Vascular Biology
• Biotechnology

Context:

• Therapeutic angiogenesis has been utilized for approximately 15 years for treating ischemic diseases.
• Significant research, including successes and failures, has generated insights and identified challenges in the field.
• Common methods involve introducing angiogenic growth factors (e.g., VEGF, bFGF, angiopoietin-1) into ischemic tissues.

Purpose:

• To review recent achievements and challenges in experimental and clinical therapeutic angiogenesis studies.
• To analyze the current state of therapeutic angiogenesis for ischemic conditions.
• To identify potential future research directions and developmental opportunities.

Summary:

• Efficacy of therapeutic angiogenesis is limited by various challenges.
• Novel delivery methods, combination therapies, and improved preclinical models are proposed solutions.
• The review analyzes key advancements and emerging issues in the field.

Impact:

• Highlights the need for innovative strategies to overcome current obstacles in therapeutic angiogenesis.
• Suggests potential pathways for advancing the treatment of ischemic diseases.
• Provides a foundation for future research and clinical development in regenerative medicine.